Psychiatr. praxi. 2012;13(4):169-173

Depression and epilepsy

MUDr.Anežka Ticháčková
Klinika psychiatrie FN Olomouc, LF UP Olomouc

Depressive disorders are frequent psychiatric comorbidities in epilepsy. They distinguish from depression in common population, they

are often unrecognized and untreated. Depressive disorders affect subsequent course and result of epilepsy treatment.

Keywords: periictal depression, interictal depression, interictal dysphoric disorder

Published: November 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ticháčková A. Depression and epilepsy. Psychiatr. praxi. 2012;13(4):169-173.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ticháčková A, Pidrman V. Epilepsie z pohledu psychiatra. Psychiatrie pro praxi 2004; 5: 222-227.
    2. Co-morbidity Epilepsy and Psychiatry. Proceedings of the Hjortviken Konferens Gothenburg, Sweden, 3-4 February 2004. Bjornaes H. Affective symptoms and seisures: The vicious circle.
    3. Kanner AM. Is Depression a Risk Factor of Worse Response to Therapy in Epilepsy? Epilepsy Curr. 2011; 11(2): 50-51. Go to original source... Go to PubMed...
    4. Hesdorffer DC, Hauser AW. Epidemiologic considerations. In: Ettinger AB, Kanner AM, editors. Psychiatric Issues in Epilepsy: A Practical Guide to Diagnosis and Treatment. Philadelphia: Lippincott, Williams & Wilkins; 2007: pp. 1-16.
    5. Hitiris N, Mohanraj R, Norrie J, Sills GJ, Brodie MJ. Predictors of pharmacoresistant epilepsy. Epilepsy Res. 2007; 75(2-3): 192-196. Go to original source... Go to PubMed...
    6. Kanner AM, Byrne R, Chicharro A, Wuu J, Frey M. A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology 2009; 72(9): 793-799. Go to original source... Go to PubMed...
    7. Schmitz B. Depression and mania in patients with epilepsy. Epilepsia. 2005; 46(Suppl 4): 45-49 Blackwell Publishing, Inc. Ettinger et al, Barraclough et al, 2004. Go to original source... Go to PubMed...
    8. Kanner AM, Palac S. Neuropsychiatric Complications of Epilepsy. Current Neurology and Neuroscience Reports 2002; 2: 365-372 Current Science Inc. Go to original source... Go to PubMed...
    9. Kanner AM, Balabanov A. Depression and epilepsy: how closely related are they? Neurology. 2002; 58(8 Suppl 5): S27-39. Go to original source... Go to PubMed...
    10. Blumer D, Altshuler LL. Affective disorders. In: Epilepsy: a comprehensive textbook, v. II, Engel J, Pedley TA, eds. Philadelphia: Lippincott-Raven, 1998: 2083-2099. Go to original source...
    11. Prueter C, Norra C. Mood Disorders and Their Treatment in Patients With Epilepsy. J Neuropsychiatry Clin Neurosci 2005; 17: 20-28. Go to original source... Go to PubMed...
    12. Elger E, Hoppe Ch. What is Depression in Epilepsy? Front Neurol. 2011; 2: 79. Go to original source... Go to PubMed...
    13. Landolt H. Some clinical electroencephalographical correlations in epileptic psychoses (twilight states). Electroencephalogr Clin Neurophysiol. 1953; 5: 121-122.
    14. Landolt H. Serial electroencephalographic investigations during psychotic episodes in epileptic patients and during schizophrenic attacks. In: Lorentz de Haas AM, ed.
    15. Salgado PC, Yasuda CL, Cendes F. Neuroimaging changes in mesial temporal lobe epilepsy are magnified in the presence of depression. Epilepsy Behav. 2010; 19(3): 422-427. Epub 2010 Sep 17. Go to original source... Go to PubMed...
    16. Co-morbidity Epilepsy and Psychiatry. Proceedings of the Hjortviken Konferens Gothenburg, Sweden, 3-4 February 2004. Koch-Stoecker S. Psychiatric Complications of Surgery for Tempoval Lobe Epilepsy.
    17. Gilliam F, Kanner AM. Treatment of depressive disorders in epilepsy patients Epilepsy & Behavior. October 2002; 5(Supp 1): 2-9.
    18. Robertson MM. Suicide, parasuicide and epilepsy. In: EngelJJr, PedleyTA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1997: 2141-2151.
    19. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Biostatistics (2008). Statistical review and evaluation: antiepileptic drugs and suicidality. May 21, 2008.
    20. Hesdorffer DC, Kanner AM. The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm?. Epilepsia. May 2009; 50(5): 978-986. Go to original source... Go to PubMed...
    21. Loyning Y, Mostofsky D. The neurobehavioral treatment of epilepsy. New Jersey: Lawrence Erlbaum Associates. 1993, pp.253-264.
    22. Nakkena KO, Solaasb MH, Kjeldsenc MJ, Friisc ML, Pellockd JM, Corey LA. Which seizure-precipitating factors do patients with epilepsy most frequently report? Epilepsy & Behavior 2005; 6(1): 85-89. Go to original source... Go to PubMed...
    23. Spector S, Cull C, Goldstein LH. Seizure precipitants and perceived self-control of seizures in adults with poorly-controlled epilepsy. Epilepsy Res. 2000; 38(2-3): 207-216. Go to original source... Go to PubMed...
    24. Fenwick P. Evocation and inhibition of seizures: behavioral treatment. Advances in Neurology 1991; 55: 163-183. Go to PubMed...
    25. Greenlee BA, Ferrell RB, Kauffman CI, McAllister TW. Complex Partial Seizures and Depression. Current Psychiatry Reports 2003; 5: 410-416. Go to original source... Go to PubMed...
    26. Traa BS, Mulholland JD, Kadam SD, Johnston MV, Comi AM. Gabapentin neuroprotection and seizure suppression in immature mouse brain ischemia. Neurology and Developmental Medicine, Kennedy Krieger Institute, Baltimore, Maryland 21205, USA. Pediatr Res. 2008; 64(1): 81-85. Go to original source... Go to PubMed...
    27. Švestka J, et al. Psychofarmaka v klinické praxi, Grada Praha, 1995.

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.